Effect of genetic background on onset and disease progression in the SOD1-G93A model of amyotrophic lateral sclerosis

被引:46
|
作者
Mancuso, Renzo [2 ,3 ]
Olivan, Sara [4 ]
Mancera, Pilar [5 ]
Pasten-Zamorano, Andrea [5 ]
Manzano, Raquel [4 ]
Casas, Caty [2 ,3 ]
Osta, Rosario [4 ]
Navarro, Xavier [1 ,2 ,3 ]
机构
[1] Univ Autonoma Barcelona, Fac Med, Unitat Fisiol Med, Grp Neuroplast & Regenerat,Inst Neurosci, E-08193 Bellaterra, Spain
[2] Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, E-08193 Bellaterra, Spain
[3] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Bellaterra, Spain
[4] Univ Zaragoza, Aragon Inst Hlth Sci, Lab Genet Biochem LAGENBIO I3A, Zaragoza, Spain
[5] Bioincubadora PCB Santander, Neurotec Pharma SL, Barcelona, Spain
来源
AMYOTROPHIC LATERAL SCLEROSIS | 2012年 / 13卷 / 03期
关键词
Motor neuron disease; neurodegeneration; SOD1-G93A mouse; background; animal model; TRANSGENIC MOUSE MODEL; SUPEROXIDE-DISMUTASE; HEXANUCLEOTIDE REPEAT; ALS; SURVIVAL; MICE; MUTATIONS; NEUROINFLAMMATION; EPIDEMIOLOGY; DEGENERATION;
D O I
10.3109/17482968.2012.662688
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Knowledge of the potential effect of genetic background in disease models is important. The SOD1-G93A transgenic mouse is the most widely used model in amyotrophic lateral sclerosis (ALS). Since these animals show considerable variability both in the onset and the progression of the disease, this study aimed to characterize the potential differences between the two most widely used strains, C56BL/6 (B6) and B6SJL. A rotarod test was carried out to assess strength and motor coordination, while electrophysiology tests were performed to evaluate the function of upper and lower motor neurons. Survival of the animals and motor neuron loss were also studied. The results did not show any background effect regarding the rotarod test, despite the differences in the pattern of decline in central and peripheral motor conduction. The onset of motor neuron abnormalities was later in B6SJL mice, but progressed more rapidly. Lifespan was longer for B6 than for B6SJL animals. In conclusion, background differences in disease onset and progression are important. The characteristics of the strain should be taken into account in experimental design of therapeutic studies.
引用
收藏
页码:302 / 310
页数:9
相关论文
共 50 条
  • [41] The effect of amyotrophic lateral sclerosis-linked exogenous SOD1-G93A on electrophysiological properties and intracellular calcium in cultured rat astrocytes
    Milosevic, Milena
    Bataveljic, Danijela
    Nikolic, Ljiljana
    Bijelic, Dunja
    Andjus, Pavle
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2016, 17 (5-6) : 443 - 451
  • [42] Arylsulfanyl pyrazolones block mutant SOD1-G93A aggregation. Potential application for the treatment of amyotrophic lateral sclerosis
    Chen, Tian
    Benmohamed, Radhia
    Arvanites, Anthony C.
    Ranaivo, Hantamalala Ralay
    Morimoto, Richard I.
    Ferrante, Robert J.
    Watterson, D. Martin
    Kirsch, Donald R.
    Silverman, Richard B.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (01) : 613 - 622
  • [43] Low-intensity pulsed ultrasound modulates disease progression in the SOD1G93Amouse G93A mouse model of amyotrophic lateral sclerosis
    Liu, Zihao
    Zhang, Huan
    Lu, Kaili
    Chen, Li
    Zhang, Yueqi
    Xu, Zhouwei
    Zhou, Hongsheng
    Sun, Junfeng
    Xu, Mengyang
    Ouyang, Qi
    Thompson, Garth J.
    Yang, Yi
    Su, Ni
    Cai, Xiaojun
    Cao, Li
    Zhao, Yuwu
    Jiang, Lixian
    Zheng, Yuanyi
    Zhang, Xiaojie
    CELL REPORTS, 2024, 43 (09):
  • [44] Triheptanoin delays symptom onset in the superoxide dismutase 1 (SOD1G93A) mouse model of amyotrophic lateral sclerosis
    Tefera, T.
    Yide, W.
    Ni, T. K.
    Tanya, M.
    Shyuan, N.
    Karin, B.
    JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 345 - 345
  • [45] The NADPH Oxidase Pathway Is Dysregulated by the P2X7 Receptor in the SOD1-G93A Microglia Model of Amyotrophic Lateral Sclerosis
    Apolloni, Savina
    Parisi, Chiara
    Pesaresi, Maria Grazia
    Rossi, Simona
    Carri, Maria Teresa
    Cozzolino, Mauro
    Volonte, Cinzia
    D'Ambrosi, Nadia
    JOURNAL OF IMMUNOLOGY, 2013, 190 (10): : 5187 - 5195
  • [46] Human SOD1-G93A Specific Distribution Evidenced in Murine Brain of a Transgenic Model for Amyotrophic Lateral Sclerosis by MALDI Imaging Mass Spectrometry
    Acquadro, Elena
    Caron, Ilaria
    Tortarolo, Massimo
    Bucci, Enrico M.
    Bendotti, Caterina
    Corpillo, Davide
    JOURNAL OF PROTEOME RESEARCH, 2014, 13 (04) : 1800 - 1809
  • [47] Lack of Effect of Methylene Blue in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis
    Lougheed, Rosamond
    Turnbull, John
    PLOS ONE, 2011, 6 (10):
  • [48] Evolution of the neurochemical profiles in the G93A-SOD1 mouse model of amyotrophic lateral sclerosis
    Lei, Hongxia
    Dirren, Elisabeth
    Poitry-Yamate, Carole
    Schneider, Bernard L.
    Gruetter, Rolf
    Aebischer, Patrick
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2019, 39 (07): : 1283 - 1298
  • [49] Gonadectomy and dehydroepiandrosterone (DHEA) do not modulate disease progression in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis
    Hayes-Punzo, Antonio
    Mulcrone, Patrick
    Meyer, Michael
    Mchugh, Jacalyn
    Svendsen, Clive N.
    Suzuki, Masatoshi
    AMYOTROPHIC LATERAL SCLEROSIS, 2012, 13 (03): : 311 - 314
  • [50] Neurovascular unit pathology is observed very early in disease progression in the mutant SOD1G93A mouse model of amyotrophic lateral sclerosis
    Yoshikawa, Masaaki
    Aizawa, Shin
    Oppenheim, Ronald W.
    Milligan, Carol
    EXPERIMENTAL NEUROLOGY, 2022, 353